Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Medical Virology|November 15, 2023
Comparison of anti-nucleocapsid antibody assays for the detection of SARS-CoV-2 Omicron vaccine breakthroughs after various intervals since the infectionDavid Niklas Springer, Elisabeth Reuberger, Christian Borsodi, et al.
Pain|April 30, 2020
Fundamental sex differences in morphine withdrawal-induced neuronal plasticityViktoria Hadschieff, Ruth Drdla-Schutting, David Niklas Springer, et al.
Vaccines|January 22, 2024
Measuring Variant-Specific Neutralizing Antibody Profiles after Bivalent SARS-CoV-2 Vaccinations Using a Multivariant Surrogate Virus Neutralization MicroarrayDavid Niklas Springer, Eva Höltl, Katja Prüger, et al.
Diagnostics (Basel, Switzerland)|April 26, 2024
A Multivariant Surrogate Virus Neutralization Test Demonstrates Distinct SARS-CoV-2-Specific Antibody Responses in People Living with HIV after a Fourth Monovalent mRNA Vaccination or an Omicron Breakthrough InfectionDavid Niklas Springer, Simon Daller, Michael Knappik, et al.
Vaccines|October 26, 2024
The PreS-Based Recombinant Vaccine VVX001 Induces Hepatitis B Virus Neutralizing Antibodies in a Low-Responder to HBsAg-Based HBV VaccinesInna Tulaeva, Felix Lehmann, Nora Goldmann, et al.
Microbiology Spectrum|January 9, 2023
Comprehensive Comparison of Seven SARS-CoV-2-Specific Surrogate Virus Neutralization and Anti-Spike IgG Antibody Assays Using a Live-Virus Neutralization Assay as a ReferenceMarianne Graninger, Claudia Maria Jani, Elisabeth Reuberger, et al.
Diagnostics (Basel, Switzerland)|July 14, 2023
A Multivariant Surrogate Neutralization Assay Identifies Variant-Specific Neutralizing Antibody Profiles in Primary SARS-CoV-2 Omicron InfectionDavid Niklas Springer, Marianna Traugott, Elisabeth Reuberger, et al.
One Health Outlook|October 28, 2024
Launching Austria's One Health network: paving the way for transdisciplinary collaborationsAmélie Desvars-Larrive, Pamela Burger, Johannes Lorenz Khol, et al.
Microbiology Spectrum|August 25, 2022
Reduced Sensitivity of Commercial Spike-Specific Antibody Assays after Primary Infection with the SARS-CoV-2 Omicron VariantDavid Niklas Springer, Thomas Perkmann, Claudia Maria Jani, et al.
Pageof 1